Insider and congress filings

ResMed Inc. (RMD)

NYSE · Healthcare · 334 insider transactions · 51 congress trades · last filed 18 days agoS&P 500

20
Open-market insider filings shown
2d
Median delay on the insider filings, in business days
within the two business day rule
0 buys·20 sells
Purchases and sales in the filings shown
Get a push when an insider at ResMed Inc. trades.

Free on iOS and Android.

About ResMed Inc.

from the company's filings and listing, as of Oct 25, 2026
Exchange
NYSE
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Chief executive
Michael J. Farrell
Employees
11,370
Listed since
Jun 2, 1995
Market value
$35.6B
Price to earnings (12 mo)
24.2
Net income per share, as reported (12 mo)
$10.53
Dividend yield
0.97%

www.resmed.com

Earnings

6 reported quarters · next on Oct 29, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q4 FY2026reported Aug 6, 2026$2.95$2.89$1.5B$1.5BEPS beatRevenue in line
Q3 FY2026reported Apr 30, 2026$2.86$2.80$1.4B$1.4BEPS beatRevenue in line
Q2 FY2026reported Jan 29, 2026$2.81$2.74$1.4B$1.4BEPS beatRevenue beat
Q1 FY2026reported Oct 30, 2025$2.55$2.51$1.3B$1.3BEPS beatRevenue in line
Q4 FY2025reported Jul 31, 2025$2.55$2.46$1.3B$1.3BEPS beatRevenue in line
Q3 FY2025reported Apr 23, 2025$2.37$2.38$1.3B$1.3BEPS in lineRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$2.4B12,317,194+1.8%8.51%
Vanguard Capital Management LLC$1.8B9,474,129+0.1%6.55%
Vanguard Portfolio Management LLC$1.5B7,913,661+0.6%5.47%
State Street Corp$1.3B6,680,735+0.6%4.62%
Geode Capital Management, LLC$845.2M4,352,3200.0%3.01%
Bank of New York Mellon Corp$818.0M4,197,610-14.8%2.90%
First Trust Advisors LP$444.1M2,278,696+48.2%1.57%
Invesco Ltd.$402.1M2,063,578+5.5%1.43%
Morgan Stanley$375.9M1,928,931-28.2%1.33%
Northern Trust Corp$330.6M1,696,674-1.7%1.17%
Nordea Investment Management AB$269.6M1,388,008+34.3%0.96%
Deutsche Bank AG$257.7M1,322,313-7.1%0.91%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next RMD filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Open-market insider trades

20 filings shown · newest filing first
InsiderActionSharesPriceValueTrade dateDelay
(business days)
Michael J. FarrellChairman and CEOSold · scheduled4,991$226.33$1.1MOct 7, 2026filed Oct 8, 20261d
Michael J. FarrellChairman and CEOSold · scheduled4,991$222.44$1.1MSep 8, 2026filed Sep 10, 20262d
Peter C. FarrellDirectorSold · scheduled970$234.73$228KSep 2, 2026filed Sep 4, 20262d
Michael J. FarrellChairman and CEOSold · scheduled4,991$205.69$1.0MAug 7, 2026filed Aug 11, 20262d
Peter C. FarrellDirectorSold · scheduled8,000$225.00$1.8MAug 5, 2026filed Aug 6, 20261d
Michael J. FarrellChairman and CEOSold · scheduled4,991$218.55$1.1MJul 7, 2026filed Jul 9, 20262d
Michael J. FarrellChairman and CEOSold · scheduled4,991$193.96$968KJun 8, 2026filed Jun 9, 20261d
Michael J. FarrellChairman and CEOSold · scheduled4,991$207.82$1.0MMay 7, 2026filed May 11, 20262d
Michael J. FarrellChairman and CEOSold · scheduled4,991$225.50$1.1MApr 7, 2026filed Apr 9, 20262d
Brett SandercockChief Financial OfficerSold · scheduled1,000$224.31$224KApr 1, 2026filed Apr 3, 20262d
Peter C. FarrellDirectorSold · scheduled2,000$225.00$450KApr 1, 2026filed Apr 2, 20261d
Michael J. FarrellChairman and CEOSold · scheduled4,991$251.03$1.3MMar 9, 2026filed Mar 11, 20262d
Peter C. FarrellDirectorSold · scheduled2,000$260.22$520KMar 4, 2026filed Mar 5, 20261d
Brett SandercockChief Financial OfficerSold · scheduled1,000$254.30$254KMar 2, 2026filed Mar 3, 20261d
Michael J. FarrellChairman and CEOSold · scheduled4,991$273.78$1.4MFeb 9, 2026filed Feb 10, 20261d
Michael J. RiderGlobal General CounselSold · scheduled50$260.00$13KFeb 4, 2026filed Feb 6, 20262d
Peter C. FarrellDirectorSold · scheduled2,000$251.31$503KFeb 4, 2026filed Feb 6, 20262d
Brett SandercockChief Financial OfficerSold · scheduled1,000$257.03$257KFeb 2, 2026filed Feb 3, 20261d
Peter C. FarrellDirectorSold · scheduled2,000$248.83$498KJan 7, 2026filed Jan 9, 20262d
Michael J. FarrellChairman and CEOSold · scheduled4,991$248.46$1.2MJan 7, 2026filed Jan 8, 20261d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (20)
InsiderEventSharesDate
Michael J. FarrellChairman and CEOOption exercise4,991Oct 7, 2026
Justin LeongChief Product OfficerStock award6,461Aug 14, 2026
Michael J. RiderGlobal General CounselStock award3,230Aug 14, 2026
Michael J. FarrellChairman and CEOStock award13,547Aug 14, 2026
Aaron BloomerChief Financial OfficerStock award9,072Aug 14, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Sep 8, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Aug 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Jul 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Jun 8, 2026
Michael J. FarrellChairman and CEOOption exercise4,991May 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Apr 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Mar 9, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Feb 9, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Jan 7, 2026
Michael J. FarrellChairman and CEOOption exercise4,991Dec 8, 2025
Nicole Mowad-NassarDirectorStock award1,331Nov 24, 2025
Peter C. FarrellDirectorStock award1,331Nov 24, 2025
Michael J. FarrellChairman and CEOStock award33,288Nov 24, 2025
Peter C. FarrellDirectorStock award536Nov 20, 2025
Jan De WitteDirectorStock award1,073Nov 20, 2025

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

Congress trades in RMD

20 disclosures of 51 on record · median 16d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 25, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Ro KhannaStockPurchase$1,001 - $15,000+17.5%S&P 500 +0.3% · +17.2 pts vs S&P 500Aug 3, 2026Sep 4, 202632d
Alan ArmstrongSelfStockPurchase$1,001 - $15,000+14.7%S&P 500 +19.8% · -5.1 pts vs S&P 500Mar 27, 2026Jul 21, 2026116d
Ro KhannaStockPurchase$1,001 - $15,000+30.4%S&P 500 +1.3% · +29.1 pts vs S&P 500Jun 16, 2026Jul 6, 202620d
Ro KhannaStockSale$1,001 - $15,000+29.8%After the saleS&P 500 +1.7% · +28.0 pts vs S&P 500Jun 30, 2026Jul 6, 20266d
Ro KhannaStockPurchase$1,001 - $15,000+23.3%S&P 500 +5.4% · +17.9 pts vs S&P 500May 1, 2026Jun 9, 202639d
Ro KhannaStockSale$1,001 - $15,000+25.3%After the saleS&P 500 +2.8% · +22.4 pts vs S&P 500May 15, 2026Jun 9, 202625d
Ro KhannaStockPurchase$1,001 - $15,000+22.7%S&P 500 +1.3% · +21.4 pts vs S&P 500May 27, 2026Jun 9, 202613d
Ro KhannaStockPurchase$1,001 - $15,000+9.8%S&P 500 +10.8% · -0.9 pts vs S&P 500Apr 13, 2026May 11, 202628d
Ro KhannaStockPurchase$1,001 - $15,000+15.0%S&P 500 +6.4% · +8.6 pts vs S&P 500Apr 24, 2026May 11, 202617d
Ro KhannaStockSale$1,001 - $15,000+10.9%After the saleS&P 500 +15.6% · -4.7 pts vs S&P 500Mar 23, 2026Apr 7, 202615d
Ro KhannaStockSale$1,001 - $15,000+14.9%After the saleS&P 500 +20.3% · -5.3 pts vs S&P 500Mar 30, 2026Apr 7, 20268d
Ro KhannaStockPurchase$1,001 - $15,000+0.5%S&P 500 +10.5% · -10.0 pts vs S&P 500Feb 24, 2026Mar 9, 202613d
Ro KhannaStockSale$1,001 - $15,000-1.8%After the saleS&P 500 +9.5% · -11.3 pts vs S&P 500Jan 29, 2026Feb 6, 20268d
Ro KhannaStockSale$1,001 - $15,000+0.2%After the saleS&P 500 +10.2% · -10.0 pts vs S&P 500Jan 23, 2026Feb 6, 202614d
Kelly MorrisonStockSale$1,001 - $15,000+1.2%After the saleS&P 500 +27.6% · -26.4 pts vs S&P 500Jun 4, 2025Jun 18, 202514d
Ro KhannaStockPurchase$1,001 - $15,000+3.3%S&P 500 +29.3% · -26.0 pts vs S&P 500May 28, 2025Jun 10, 202513d
Kelly MorrisonStockSale$1,001 - $15,000+8.0%After the saleS&P 500 +37.9% · -29.9 pts vs S&P 500Apr 28, 2025May 13, 202515d
Ro KhannaStockSale$1,001 - $15,000+17.9%After the saleS&P 500 +42.0% · -24.0 pts vs S&P 500Apr 23, 2025May 12, 202519d
Ro KhannaStockPurchase$1,001 - $15,000+12.4%S&P 500 +32.6% · -20.3 pts vs S&P 500Mar 6, 2025Apr 10, 202535d
Robert BresnahanJointStockSale$1,001 - $15,000+9.8%After the saleS&P 500 +30.7% · -20.9 pts vs S&P 500Jan 13, 2025Feb 13, 202531d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in RMD, filterable by party, chamber, type and account.

Members of Congress reporting a position

4 members · estimate, as of Oct 24, 2026

4 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Robert BresnahanRepublican · House$15,001 - $50,0000.1%
Gilbert Ray Cisneros, Jr.Democrat · House$1,001 - $15,000<0.1%
Julie JohnsonDemocrat · House$1,001 - $15,0000.1%
Lucy McBathDemocrat · House$1,001 - $15,0000.1%

Estimate, as of Oct 24, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Are insiders buying or selling RMD?

Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. 20 were scheduled in advance under a Rule 10b5-1 plan.

Which members of Congress have traded RMD?

Ro Khanna, Alan Armstrong, Kelly Morrison and Robert Bresnahan disclosed RMD transactions in the filings shown here.

Which members of Congress hold RMD?

4 members of Congress report a position in RMD in the estimate we hold as of Oct 24, 2026. The largest estimated position belongs to Robert Bresnahan; the next largest, in the $1,001 - $15,000 band, include Gilbert Ray Cisneros, Jr. and Julie Johnson. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is RMD in the S&P 500 or the Nasdaq 100?

ResMed Inc. is a current member of the S&P 500, per the membership list we hold as of Oct 26, 2026. Current members of either index get a page here whatever their filing history.

How quickly are RMD trades disclosed?

Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 16 days, against the 45 the STOCK Act allows.

How to read a Form 4

A DECISION THE INSIDER MADE

POpen-market purchase. Bought with their own money at the market price.
SOpen-market sale. Sold on the market. A sale marked scheduled was set up in advance under a Rule 10b5-1 plan, often months before.

COMPENSATION PLUMBING

AStock award. Granted as pay, not bought.
MOption exercise. Converting options already held into shares.
FTax withholding. Shares handed back to the company to pay the tax on a grant.
GGift. Given away, with no money changing hands.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track